Novel oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) and diabetes-Good or excellent?
Autor: | Shaul AA; Cardiology Department, Rabin Medical Center, Petah Tikva, Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Eisen A; Cardiology Department, Rabin Medical Center, Petah Tikva, Israel and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. |
---|---|
Jazyk: | angličtina |
Zdroj: | Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2017 Jul; Vol. 33 (5). Date of Electronic Publication: 2017 Apr 11. |
DOI: | 10.1002/dmrr.2893 |
Databáze: | MEDLINE |
Externí odkaz: |